Refinement of clinicobiological procedures such as neuroimaging and biomarker analysis have led to reexamination of existing diagnostic nosology with an emphasis on early, and even pre-clinical identification of neurodegenerative pathology in Alzheimer's disease (AD), Frontotemporal Dementia (FTD), and Dementia with Lewy Bodies (DLB). As these technologies develop, there is an increasing demand for accurate clinical validation via behavioral and neurocognitive measures. This chapter will provide the current status of neurocognitive assessment as it relates to dementia diagnosis, review psychometric properties, and provide useful information for investigators wishing to include neurocognitive assessment in study protocols.
|Title of host publication||Neuropsychology|
|Subtitle of host publication||New Research|
|Number of pages||15|
|State||Published - Mar 2013|
ASJC Scopus subject areas
- Medicine (all)
- Psychology (all)